Growth Metrics

Mannkind (MNKD) Operating Expenses (2010 - 2026)

Mannkind (MNKD) reported Operating Expenses of $91.8 million for Q1 2026, up 63.82% year-over-year from $56.1 million in Q1 2025, and down 23.24% on a QoQ basis from $119.6 million in Q4 2025.

Mannkind (MNKD) has 17 years of Operating Expenses data on file, last reported at $91.8 million in Q1 2026.

  • Quarterly Operating Expenses rose 63.82% year-over-year to $91.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $345.9 million (up 57.65% YoY) and the FY2025 annual result came in at $310.2 million, up 45.67% from the prior year.
  • Operating Expenses slipped to $91.8 million in Q1 2026 per MNKD's latest filing, from $119.6 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $119.6 million in Q4 2025 and bottomed at $33.2 million in Q1 2022.
  • The 5-year median for Operating Expenses is $50.3 million (2024), against an average of $57.0 million.
  • The widest annual swing landed in 2024, when Operating Expenses fell 0.66%; it then soared 137.95% in 2025.
  • Tracing MNKD's Operating Expenses over 5 years: stood at $48.8 million in 2022, then advanced by 3.61% to $50.6 million in 2023, then fell by 0.66% to $50.3 million in 2024, then soared by 137.95% to $119.6 million in 2025, then slipped by 23.24% to $91.8 million in 2026.
  • Per Business Quant, the three latest MNKD Operating Expenses figures stand at $91.8 million (Q1 2026), $119.6 million (Q4 2025), and $63.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.97 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 4.33 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -138.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 15.76 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.85 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -3.82 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.96 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 898.54 Mn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn 91.84 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 91.84 Mn
Dec 31, 2025 119.64 Mn
Sep 30, 2025 63.23 Mn
Jun 30, 2025 71.23 Mn
Mar 31, 2025 56.06 Mn
Dec 31, 2024 50.28 Mn
Sep 30, 2024 57.32 Mn
Jun 30, 2024 55.78 Mn
Mar 31, 2024 49.54 Mn
Dec 31, 2023 50.61 Mn
Sep 30, 2023 46.16 Mn
Jun 30, 2023 46.89 Mn
Mar 31, 2023 46.62 Mn
Dec 31, 2022 48.85 Mn
Sep 30, 2022 42.44 Mn
Jun 30, 2022 39.35 Mn
Mar 31, 2022 33.25 Mn
Dec 31, 2021 36.48 Mn
Sep 30, 2021 28.80 Mn
Jun 30, 2021 33.55 Mn
Mar 31, 2021 23.63 Mn
Dec 31, 2020 42.19 Mn
Sep 30, 2020 24.48 Mn
Jun 30, 2020 23.03 Mn
Mar 31, 2020 23.36 Mn
Dec 31, 2019 27.35 Mn
Sep 30, 2019 23.37 Mn
Jun 30, 2019 25.95 Mn
Mar 31, 2019 30.96 Mn
Dec 31, 2018 23.76 Mn
Sep 30, 2018 26.01 Mn
Jun 30, 2018 24.43 Mn
Mar 31, 2018 30.25 Mn
Dec 31, 2017 33.37 Mn
Sep 30, 2017 30.22 Mn
Jun 30, 2017 33.73 Mn
Mar 31, 2017 22.61 Mn
Dec 31, 2016 24.24 Mn
Sep 30, 2016 44.13 Mn
Jun 30, 2016 19.12 Mn
Mar 31, 2016 20.01 Mn
Dec 31, 2015 272.86 Mn
Sep 30, 2015 26.00 Mn
Jun 30, 2015 24.05 Mn
Mar 31, 2015 21.74 Mn
Dec 31, 2014 30.10 Mn
Sep 30, 2014 38.27 Mn
Jun 30, 2014 69.85 Mn
Mar 31, 2014 41.41 Mn
Dec 31, 2013 46.62 Mn
Sep 30, 2013 44.76 Mn
Jun 30, 2013 41.59 Mn
Mar 31, 2013 36.44 Mn
Dec 31, 2012 33.49 Mn
Sep 30, 2012 35.52 Mn
Jun 30, 2012 44.05 Mn
Mar 31, 2012 33.93 Mn
Dec 31, 2011 30.58 Mn
Sep 30, 2011 32.77 Mn
Jun 30, 2011 39.19 Mn
Mar 31, 2011 38.05 Mn
Dec 31, 2010 32.09 Mn
Sep 30, 2010 42.54 Mn
Jun 30, 2010 37.36 Mn